Mauritania vs Vanuatu: The number of people with susceptibility test result for rifampicin
Mauritania
0
in 2021
Vanuatu
0
in 2021
Mauritania rank
146th
Vanuatu rank
146th
The number of people with susceptibility test result for rifampicin over time
- Mauritania
- Vanuatu
How they compare
Mauritania currently reports 0 against 0 in Vanuatu, a difference of 0.
Across all 5 years both countries report, Vanuatu has been ahead every year.
Mauritania ranks 146th and Vanuatu ranks 146th of 155 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3 | 46.33 | 43.33 | Vanuatu |
| 2020s | 0 | 21.5 | 21.5 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mauritania or Vanuatu?
- Mauritania, at 0 against 0 in Vanuatu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mauritania and Vanuatu?
- 0, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Vanuatu?
- 5 years are reported by both, from 2017 to 2021.
- How do Mauritania and Vanuatu rank globally for the number of people with susceptibility test result for rifampicin?
- Mauritania ranks 146th and Vanuatu ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.